Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 9:06pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
Enter symbol(s):
Market:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
|
Alphabetical List
Questcor Pharmaceuticals, Inc. (QCOR)
At 5:00AM SGT:
4.57 USD
0.00 (0.00%)
MORE ON QCOR
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Questcor Pharmaceuticals, Inc.
(NGM:QCOR) Delayed quote data
Last Trade:
4.57 USD
Trade Time:
5:00AM SGT
Change:
0.00 (0.00%)
Prev Close:
4.57
Open:
N/A
Bid:
4.03
x 500
Ask:
5.11
x 200
1y Target Est:
9.00
Day's Range:
N/A - N/A
52wk Range:
3.10 - 7.82
Volume:
0
Avg Vol
(3m)
:
723,765
Market Cap:
293.23M
P/E
(ttm)
:
8.91
EPS
(ttm)
:
0.51
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Use Y! Toolbar to track stocks
Add QCOR to Portfolio
Download Data
HEADLINES
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
EDGAR Online
(Fri, Feb 5)
Questcor Appoints Jason Zielonka, M.D. Chief Medical Officer
GlobeNewswire
(Thu, Feb 4)
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online
(Thu, Feb 4)
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online
(Fri, Jan 22)
Questcor Drug Gets Target Date
Zacks.com
(Wed, Dec 30)
QUESTCOR PHARMACEUTICALS INC Files SEC form 8-K, Other Events
EDGAR Online
(Tue, Dec 29)
Stocks to Watch: Stocks to watch on Monday
at MarketWatch
(Sat, Dec 26)
[$$] Stocks in the Spotlight Thursday
at Barrons.com
(Fri, Dec 25)
Stocks to Watch: Stocks to Watch for Monday
at MarketWatch
(Fri, Dec 25)
Questcor, Arena: Early Volume Plays
at TheStreet.com
(Thu, Dec 24)
FDA Accepts for Review Questcor's Filing of Its Supplemental New Drug Application for H.P. Acthar(R) Gel for Treatment of Infantile Spasms
GlobeNewswire
(Thu, Dec 24)
More Headlines for QCOR...
ANALYST
EPS Est (next year)
(Dec-09)
:
0.37
EPS Est (in 2 years)
(Dec-10)
:
0.44
Avg Rec (current)*:
2.5
PEG Ratio:
0.58
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
Questcor Pharmaceuticals, Inc., a specialty pharmaceutical company, provides prescription drugs for central nervous system disorders. The company markets H.P.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Singapore
US
----------------
Argentina
Australia
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Korea
Korea - KOSDAQ
Malaysia
Mexico
Netherlands
New Zealand
Norway
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Search by Company
Latest News
Singapore Indices